|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 209.5 TWD | -0.71% |
|
+4.49% | +7.16% |
Ever Supreme Bio Technology Co., Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was TWD 627.51 million compared to TWD 438.84 million a year ago. Net income was TWD 200.71 million compared to TWD 369.6 million a year ago.
Basic earnings per share from continuing operations was TWD 2.6827 compared to TWD 4.9561 a year ago. Diluted earnings per share from continuing operations was TWD 2.6645 compared to TWD 4.9107 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +7.16% | 475M | |
| -3.45% | 87.17B | |
| +1.97% | 40.1B | |
| -15.96% | 31.38B | |
| +58.17% | 25.12B | |
| -15.83% | 15.59B | |
| -9.12% | 12B | |
| -41.58% | 11.8B | |
| -17.41% | 11.8B | |
| +6.89% | 8.81B |
EVER SUPREME BIO TECHNOLOGY CO., LTD 
